The past year has not been particularly optimistic about the healthy development of women. The first is that the company has introduced a Bluetooth-enabled "smart tampon" that tracks their physiological cycles based on changes in female eyebrows, but the design of the device is cumbersome and impractical. At the same time, this feature has related security risks. For example, hackers may be able to access these private health data by accessing some mobile applications, although these applications are designed to help women track their menstrual cycle and fertility rate. We all hope that 2017 will get better. Fortunately, more and more startups realize that men and women have different health needs. As a result, more and more companies are now developing new products and services designed to address some of the unique health issues of women, such as childbirth and contraception. Here are some interesting women's health techniques in preparation. In the next few years, consumers will have access to the most innovative medical devices that can be used to test female signs and treat women's diseases. Needleless breast reconstruction technology This hand-held needle-free device uses compressed carbon dioxide to gradually expand tissue after mastectomy As women's double breast resection rates rise, more and more women are faced with the decision whether to perform breast reconstruction after surgery. For decades, breast implants have typically involved tissue expansion of the needle, which is very painful and inconvenient for female patients. Today's devices that have needle-free and patient-controllable devices can change the expanded tissue with a small amount of carbon dioxide. The device has been tested in a large clinical trial at Columbia University and is now awaiting FDA approval. Diagnosis of endometriosis The Dot Lab (located in San Francisco), led by Heather Bowerman, has now opened tests for the diagnosis of endometriosis. Endometriosis is a common painful condition in which patients usually grow outside the uterus rather than growing inside as normal. One in nearly 10 women worldwide has such a disease, and endometriosis is a common cause of female infertility. Often, the only way to diagnose the disease is to use some invasive procedures. In the United States, women with endometriosis take an average of 11 years to get a proper diagnosis. Heather Bowerman wants to change that. Her company has developed a blood test for the diagnosis of the disease and plans to officially launch the test in 2017. Dingmin Pharmaceutical supply Prucalopride API and Prucalopride Intermediates with high purity and best price. The main products CAS No are as follows: 748788-39-8, 232941-14-9, 179474-85-2. Sample can be sent if you request. Most of the products are stock available. Also can be custom. Cas 232941-14-9,Prucalopride Intermediates,2-Hydroxy-Benzoate Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd , https://www.dingminpharma.com
Welcome to do business with us. Please email to us directly.